Personalized Transplant Decision Making for Myelofibrosis in the Era of Molecular Genetics and JAK Inhibition
Nico Gagelmann(Universität Hamburg), Nicolaus Kröger(Universität Hamburg), Alessia Tieghi(Azienda Sanitaria Unità Locale di Reggio Emilia), Jean‐Jacques Kiladjian(Délégation Paris 5), Roberto M. Lemoli(University of Genoa), Marie Robin(Universität Hamburg), Bárbara Mora(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Mario Tiribelli(University of Udine), Maria Chiara Finazzi(Ospedale Papa Giovanni XXIII), Giulia Benevolo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Mirko Farina(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Hans Christian Reinhardt(German Cancer Research Center), Rachel B. Salit(Johns Hopkins Hospital), Richard T. Silver(Cornell University), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Andrew Kuykendall(Moffitt Cancer Center), David M. Ross(Flinders Medical Centre), Valerio De Stefano(Agostino Gemelli University Polyclinic), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Marco Ruggeri(Ospedale San Bortolo), Fabrizio Pane(Federico II University Hospital), Carmelo Gurnari(University of Rome Tor Vergata), Giuseppe A. Palumbo(University of Catania), Jason Gotlib(Stanford University), Alessandro Isidori, Simona Pagliuca(Centre Hospitalier Régional et Universitaire de Nancy), Tiziano Barbui(University of Bergamo), Massimiliano Bonifacio(University of Verona), Elisa Rumi(University of Pavia), Giovanni Caocci(University of Cagliari), Bart L. Scott(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Francesco Cavazzini(University of Ferrara), Gianni Binotto(University of Padua), Erika Morsia(Marche Polytechnic University), Margherita Maffioli, Massimo Breccia(Policlinico Umberto I), Matteo Giovanni Della Porta(Humanitas University), Timothy Devos(Rega Institute for Medical Research), Filippo Branzanti(University of Bologna), Elena Maria Elli(Azienda Ospedaliera San Gerardo), Andrea Bacigalupo(Università Cattolica del Sacro Cuore), Marie‐Thérèse Rubio, Thomas Schroeder, Jaroslaw Maciejewski, Marianna Caramella, F. Cervantes(Hospital Clínic de Barcelona), Bruno Martino(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Christina Rautenberg(Essen University Hospital), Alessandro Maria Vannucchi(University of Florence), Alessandra Iurlo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 3
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k